{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors", "item": "https://www.patentleaderboard.com/patent/10590090"}]}

Home › 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors

US Patent 10590090 · Granted Mar 17, 2020

Estimated economic value: $26,152,000 ⓘ

Assignee

Revolution Medicines

Inventors

Elena S. Koltun (39 patents)
Kevin T. Mellem (12 patents)
Adrian Liam Gill (41 patents)
Gert Kiss (8 patents)
Christopher Semko (68 patents)
Naing Aay (19 patents)
Andreas BUCKL (13 patents)
Ashutosh S. Jogalekar (6 patents)
Walter Won (21 patents)

View full patent text on Google Patents →